{Reference Type}: Review
{Title}: Dupuytren's disease - what's new: a review.
{Author}: Żyluk A;
{Journal}: Pol Przegl Chir
{Volume}: 95
{Issue}: 6
{Year}: 2022 Oct 24
暂无{DOI}: 10.5604/01.3001.0016.0058
{Abstract}: &lt;b&gt;&lt;br&gt;Introduction:&lt;/b&gt; Dupuytren's disease is a common fibrotic disorder of the palmar aponeurosis characterized by the formation of nodules and cords, as well as development of progressive flexion deformities in the digits, leading to functional impairment. Surgical excision of the affected aponeurosis remains the most common treatment. Quite a few new information appeared about epidemiology, pathogenesis and particularly treatment of the disorder.&lt;/br&gt; &lt;b&gt;&lt;br&gt;Aim:&lt;/b&gt; The aim of this study is an updated review of scientific data in this topic.&lt;/br&gt; &lt;b&gt;&lt;br&gt;Results:&lt;/b&gt; Results of epidemiologic studies showed that Dupuytren's disease is not so uncommon in Asian and African population as it was earlier believed. An important role of genetic factors on development of the disease in a proportion of patients was demonstrated, however, it did not translate neither to the treatment nor to the prognosis. The most changes concerned the management of Dupuytren's disease. A positive effect of steroids injections into the nodules and cords for inhibition of the disease in early stages was shown. In the advanced stages, a standard technique of partial fasciectomy was partly replaced by mini-invasive methods such as needle fasciotomy and collagenase Clostirdium hystolyticum injections. Unexpected withdrawal of collagenase from the market in 2020 resulted in considerable limitation of the availability of this treatment.&lt;/br&gt; &lt;b&gt;&lt;br&gt;Conclusion:&lt;/b&gt; It seems that updated knowledge on Dupuytren's disease may be interested and useful for surgeons involved in management of the disorder.&lt;/br&gt.